Cite
Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.
MLA
Vos, Wilhelm A. J. W., et al. “Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-Nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.” Viruses (1999-4915), vol. 16, no. 4, Apr. 2024, p. 582. EBSCOhost, https://doi.org/10.3390/v16040582.
APA
Vos, W. A. J. W., Vadaq, N., Matzaraki, V., Otten, T., Groenendijk, A. L., Blaauw, M. J. T., van Eekeren, L. E., Brinkman, K., de Mast, Q., Riksen, N. P., Stalenhoef, A. F. H., van Lunzen, J., van der Ven, A. J. A. M., Blok, W. L., & Stalenhoef, J. E. (2024). Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies. Viruses (1999-4915), 16(4), 582. https://doi.org/10.3390/v16040582
Chicago
Vos, Wilhelm A. J. W., Nadira Vadaq, Vasiliki Matzaraki, Twan Otten, Albert L. Groenendijk, Marc J. T. Blaauw, Louise E. van Eekeren, et al. 2024. “Cardiometabolic Differences in People Living with HIV Receiving Integrase Strand Transfer Inhibitors Compared to Non-Nucleoside Reverse Transcriptase Inhibitors: Implications for Current ART Strategies.” Viruses (1999-4915) 16 (4): 582. doi:10.3390/v16040582.